Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23560)

• Formulation Name: Terazosin Hydrochloride eq 1mg base tablet
• Company: Abbott Laboratories Pharmaceutical Products Div

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Terazosin	(DM3JCVS)	Benign prostatic hyperplasia	GA90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Povidone	(E00667)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent
Pregelatinized starch	(E00674)	Not Available	Binding agent; Diluent; Disintegrant
Talc	(E00520)	16211421	Anticaking agent; Diluent; Glidant; lubricant